Colorectal cancer was once considered primarily a disease of aging. But rates are now on the rise among younger adults. Since 2011, colon cancer rates among people younger than 50 have increased by ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

WASHINGTON (DC News Now) — A new blood test may make it much easier and cheaper to screen for signs of colon cancer. Test manufacturer Guardant said the Food and Drug Administration (FDA) approved its ...

For adults with average cancer risk, a blood test could provide an option for colon cancer screening instead of a colonoscopy. The Food and Drug Administration has approved a blood test, Shield, that ...

Colorectal cancer (CRC) remains a major global health challenge, with early detection proving essential for effective treatment and improved patient outcomes. Fecal immunochemical testing (FIT) has ...

It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t cancel your colonoscopy just yet — that old standby is still more reliable ...

INDIANAPOLIS (WISH) – This week, the United States Food and Drug Administration approved Guardant’s Shield blood test to screen for colon cancer in average-risk Americans 45 to 75 years old.

For years, the gold standard in screening for colon cancer has been a colonoscopy. But a colonoscopy is a medical procedure that involves length prep work, along with being put under, making it ...

FILE - A sign for the U.S. Food and Drug Administration is displayed outside their offices in Silver Spring, Md., Dec. 10, 2020. U.S. health regulators on Monday, July 29, 2024, approved a ...

(NEXSTAR) — An unexpected delivery at your door may not always be an unwelcome surprise — just ask one Kentucky boy about the thousands of dollars worth of lollipops that arrived at his home earlier ...